DocGo Inc.

DCGO Healthcare Medical Care Facilities

DocGo Inc.’s revenue for fiscal 2025 (year ended December 2025) was $322.2 million, down 47.7% from fiscal 2024.

Revenue
−8.70%
EPS
−45.5%
Free cash flow
−132.3%
Total debt
+7,140.9%

Quarter to June 2026, against a year earlier

0.25 0.01 +4.17%
Market cap
$24.1M
P/E
0.0×
Fwd P/E
−0.5×
Dividend yield
—
F-score
3/9
Altman Z
−1.37
Beneish M
−8.29
Dividend safety
45/100

Insider Decisions last twelve months

Sold, $m 0.02
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell 1 — — — — — — — — — — —
Insider Ownership 6.33%

Capital & Financial Ratios $m

Size
Market Cap 24.12
Revenue ttm 294.72
Net income ttm (206.69)
Free cash flow ttm (28.57)
Net debt Q (25.07)
Valuation
P/E 0.00
Forward P/E (0.49) (negative: loss-making)
Price / sales 0.08
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.26
Financial health
Current ratio Q 1.66 (at or above 1.5: strong)
Debt / equity Q 0.00 (at or below 0.5: strong)
Interest coverage Q (183.63)
Growth
Revenue growth Q −8.70% (below 0%: shrinking)
Operating income growth Q −2.53% (below 0%: shrinking)
EPS, this year +72.42% (at or above 15%: strong)
EPS, next year A +46.80% (at or above 15%: strong)
Revenue, next year A −4.87% (below 0%: weak)
EPS, past 5 yrs —
EPS, next 5 yrs A +44.18% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/S against its own 10 years 0.49%
10-year low 10-year high
P/B against its own 10 years 4.95%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 59 89 51 25
Receivables 262 211 93 86
Inventory — — — —
Other — 0 4 4
339 304 152 120
2023 2024 2025 Q'26
Payables 20 28 11 14
ST’ Debt — — — —
Other 28 5 3 9
170 122 67 72

Compound Annual Growth %

10y 5y 3y
Sales — 27.91% (9.90%)
Cash Flow — 0.00% 6.07%
Earnings — 0.00% 0.00%
Book Value — 13.46% (23.30%)

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 (0.15) (0.16) — — —
’25 (0.09) (0.11) (0.28) (1.37) (1.84)
’24 0.10 0.06 0.05 (0.04) 0.18
’23 (0.03) (0.02) 0.05 0.07 0.06
’22 0.09 0.11 0.03 0.09 0.34
’21 (0.03) 1.13 0.01 0.21 0.25
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 76 73 — — —
’25 96 80 71 75 322
’24 192 165 139 121 617
’23 113 125 187 199 624
’22 118 110 104 109 441
’21 50 62 86 121 319
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (5) (9) — — —
’25 9 34 2 (10) 34
’24 (11) 37 31 13 70
’23 (23) 11 (46) (6) (64)
’22 18 12 7 (9) 29
’21 (1) 0 8 (9) (2)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (6) (10) — — —
’25 8 32 0 (13) 27
’24 (12) 35 30 12 65
’23 (26) 9 (47) (9) (74)
’22 17 11 5 (10) 23
’21 (3) (2) 7 (11) (9)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — — 94 319 441 624 617 322 295 +27.9% 307 326 337 +1.5%
Gross margin, % — — — — 33.32 34.43 35.12 31.30 34.64 30.65 30.12 (2.7) pt
EBT — — — — (15) 20 23 16 28 (187) (189) +66.5%
EBT margin, % — — — — (15.55) 6.21 5.17 2.61 4.50 (58.19) (64.26) (42.6) pt
Net income — 0 — — (15) 19 31 10 13 (196) (207) n/m
Per share, $
Per share, $ Revenue — — — — 1.61 3.97 4.35 6.03 6.02 3.25 2.98 +15.1%
Earnings — — — — (0.25) 0.30 0.34 0.07 0.20 (1.84) (1.96) +48.7%
Cash flow — — — — (0.18) (0.02) 0.29 (0.62) 0.68 0.35 (0.23) n/m
Capex — — — — (0.10) (0.08) (0.05) (0.09) (0.05) (0.07) (0.06) (6.7%)
Free cash flow — — — — (0.29) (0.11) 0.23 (0.71) 0.63 0.27 (0.29) n/m
Book value — — — — 1.15 2.83 2.76 2.95 3.08 1.27 0.97 +2.1%
Shares, m — — — — 58 80 101 104 102 99 99 +11.2%
Valuation, ×
Valuation, × P/E — — — — 0.00 7.10 20.53 73.86 22.32 0.00 0.00 20.6
P/S — — — — 0.00 2.36 1.70 0.86 0.70 0.27 0.08 1.0
P/B — — — — 2.18 3.31 2.68 1.75 1.38 0.69 0.26 2.0
EV/Sales — — — — 0.00 1.81 1.34 0.76 0.56 0.11 0.00 0.8
EV/FCF — — — — 0.00 (67.19) 25.33 (6.47) 5.32 1.34 0.01 (6.9)
Cash, $m
Cash, $m Operating cash flow — — — — (11) (2) 29 (64) 70 34 (23) n/m
Capex — — — — (6) (7) (5) (9) (5) (7) (6) +3.7%
Free cash flow — — — — (17) (9) 23 (74) 65 27 (29) n/m
Balance, $m
Balance, $m Working capital — — — — 35 198 171 169 183 85 47 +19.4%
Net debt — — — — (32) (174) (156) (59) (89) (51) (25) +9.8%
Shareholders’ equity — — — — 67 227 279 305 315 126 96 +13.5%
Returns, %
Returns, % ROA — — — — (28.67) 11.59 9.84 1.55 4.23 (54.23) (64.67) (25.6) pt
ROIC — — — — (26.26) 18.17 11.11 3.83 7.94 (148.29) (161.93) (122.0) pt
ROE — — — — (10.46) 16.15 13.67 2.35 6.45 (82.71) (100.35) (72.2) pt
People
People Employees — — — — 4 2,924 3,252 4,164 4,407 3,568 — +289.1%
Revenue/emp, $m — — — — 23.52 0.11 0.14 0.15 0.14 0.09 — (67.1%)
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

DocGo Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
AIRS AirSculpt Technologies, Inc. $103.8M — (loss-making) — (loss-making) −8.71% (below 0%: shrinking) n/m −813.83% (below 0%: shrinking) 0.00% 0.00% Compare
PARK Park Dental Partners, Inc. $95.8M — (loss-making) — +12.15% (above 0%: growing) −65.84% (below 0%: shrinking) −34.78% (below 0%: shrinking) 14.37% 1.90% Compare
BMGL Basel Medical Group Ltd $70.5M — — — — — — — Compare
CCEL Cryo-Cell International Inc. $39.9M — (loss-making) 65.1× −0.02% (below 0%: shrinking) +77.78% (above 0%: growing) −58.37% (below 0%: shrinking) 79.38% 28.04% Compare
BTMD biote Corp. $37.4M 6.6× — (loss-making) −9.48% (below 0%: shrinking) n/m −174.16% (below 0%: shrinking) 65.38% (7.93%) Compare
PIII P3 Health Partners Inc. $28.1M — (loss-making) — +8.60% (above 0%: growing) n/m −272.24% (below 0%: shrinking) 22.26% 10.67% Compare
DCGO DocGo Inc. $24.1M — (loss-making) — (loss-making) −8.70% (below 0%: shrinking) n/m −132.28% (below 0%: shrinking) 30.52% (24.41%)
CCM Concord Medical Services Holdings Limited $10.0M — (loss-making) — (loss-making) +37.65% (above 0%: growing) n/m −281.45% (below 0%: shrinking) (13.15%) 0.00% Compare
AMS American Shared Hospital Services $7.8M — (loss-making) 1.8× +19.22% (above 0%: growing) n/m +195.82% (above 0%: growing) 17.00% (7.22%) Compare
Median of peers $38.6M — — +8.60% — −174.16% 17.00% 0.00%

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 22 April 2026

Ownership

Directors and executive officers, together 5.10%
Entities affiliated with BlackRock, Inc. 6.60%
Deerfield Mgmt, L.P. and its affiliates 5.10%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

DocGo Inc. (DCGO) Latest News

17 Aug

Impact 3 · · MarketBeat transcript

11 May

Impact 4 · · MarketBeat
Impact 4 · · The Motley Fool transcript
Impact 4 · · Business Wire

16 Mar

Impact 4 · · Moby
Impact 4 · · MarketBeat
Impact 4 · · The Motley Fool transcript
Impact 4 · · Business Wire

10 Nov

Impact 4 · · Business Wire
Impact 3 · · ZacksGuruFocus.comZacksZacksZacksZacksZacksZacks

22 Oct

Impact 4 · · Simply Wall St.
stockrow.com/DCGO · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com